The survey results explore supply chain challenges, demand volatility, dosage form trends, and more after a dramatic year
Newly released survey results offer insights into current product lifecycle supply chain challenges experienced by innovator and generics pharmaceutical organisations, disruptions caused by the COVID-19 pandemic, personnel staffing strains, future market directions, and more.
Pharmaceutical executives shared views on:
The results of this survey are an interesting window into both long-existing industry challenges, issues worsened by the volatility of the pandemic, and the evolutions of a changing market.
Learn more about the Survey Report.